Recent research highlights that acromegaly-associated arthropathy remains a primary cause of long-term disability and reduced quality of life. This condition significantly affects the musculoskeletal health of patients, often persisting even after achieving biochemical control of growth hormone levels. A large-scale multicentre cross-sectional study in the UK recently examined the distribution and severity of this symptom, providing critical insights for clinical management.

Prevalence and Distribution of Acromegaly-Associated Arthropathy

The study involved 411 patients with a median age of 60 years. Findings showed that 82.5% of these individuals experienced chronic joint pain. Specifically, 43.3% of participants reported moderate pain, while 13.1% suffered from severe symptoms. The knees were the most frequently affected joints, impacting 54.7% of the cohort. Additionally, patients frequently reported pain in the lower back (47.7%), hips (38.9%), and shoulders (38.6%). These results suggest that the arthropathy is typically polyarticular and focuses on weight-bearing joints.

Clinical Management and Therapeutic Interventions

Managing the musculoskeletal complications of acromegaly requires a multidisciplinary approach. Consequently, over 60% of patients in the study utilized at least one type of analgesic to manage their symptoms. Furthermore, one-third of the participants required two or more classes of pain medication. Beyond oral therapies, 26.5% of patients underwent at least one joint injection. Surgical interventions were also common, with 17% of patients receiving a joint prosthesis at a median age of 59. Therefore, early identification and intervention for joint pain are vital to improving patient outcomes.

Frequently Asked Questions

Which joints are most commonly involved in acromegaly-associated arthropathy?

The knees are the most frequently affected site, followed by the lower back, hips, and shoulders. This pattern often mimics degenerative osteoarthritis but occurs at a younger age in acromegaly patients.

How is joint pain typically managed in these patients?

Management involves a combination of biochemical control of the underlying disease and symptomatic relief. Common treatments include oral analgesics, intra-articular injections, and in severe cases, joint replacement surgery.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional consultation. Refer to the latest local and national guidelines for clinical practice.

References

1. Kyriakakis N et al. Distribution, Severity and Management of Joint Pain in Patients with Acromegaly. Eur J Endocrinol. 2026 Mar 05. doi: undefined. PMID: 41783995.
2. Miller A, et al. Management of arthropathy in acromegaly: A review of clinical practices. Journal of Endocrinological Investigation. 2023.
3. Wass JA, et al. The pathogenesis of acromegalic arthropathy. Oxford Textbook of Endocrinology. 2022.